Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$7.79 USD
-0.14 (-1.77%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.82 +0.03 (0.39%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -3.77 |
EPS Last Quarter | -3.10 |
Last EPS Surprise | -148.00% |
ABR | 2.43 |
Earnings ESP
|
-23.87% |
---|---|
Current Year | -12.09 |
Next Year | -16.61 |
EPS (TTM) | -39.35 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.00M | 13.10M | 92.10M | 61.80M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 26.00M | 26.00M | 108.00M | 67.60M |
Low Estimate | 20.00M | 0.20M | 76.20M | 56.00M |
Year ago Sales | 2.14M | 4.25M | 8.57M | 92.10M |
Year over Year Growth Est. | 974.77% | 208.24% | 974.30% | -32.90% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -3.77 | -5.65 | -12.09 | -16.61 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -4.67 | -8.63 | -16.63 | -20.49 |
High Estimate | -2.87 | -2.66 | -2.14 | -13.75 |
Low Estimate | -4.67 | -8.63 | -17.50 | -20.49 |
Year ago EPS | -16.50 | -14.00 | -65.25 | -12.09 |
Year over Year Growth Est. | 77.15% | 59.64% | 81.47% | -37.41% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 0 | 0 |
Down Last 60 Days | 0 | 2 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -3.77 | -5.65 | -12.09 | -16.61 |
7 Days Ago | -3.77 | -5.65 | -12.09 | -16.61 |
30 Days Ago | -4.94 | -4.83 | -12.63 | -18.53 |
60 Days Ago | -7.00 | -2.63 | -15.75 | -18.33 |
90 Days Ago | -7.00 | -2.63 | -15.75 | -18.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -4.67 | -8.63 | -16.63 | -20.49 |
Zacks Consensus Estimate | -3.77 | -5.65 | -12.09 | -16.61 |
Earnings ESP | -23.87% | -52.88% | -37.55% | -23.34% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.10 | -5.75 | -14.00 | -16.50 | NA |
Estimate | -1.25 | -9.25 | -15.25 | -15.75 | NA |
Difference | -1.85 | 3.50 | 1.25 | -0.75 | 0.54 |
Surprise | -148.00% | 37.84% | 8.20% | -4.76% | -26.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more